Sites of action of IL‐1 in the development of fever and cytokine responses to tissue inflammation in the rat
- 1 March 1997
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 120 (7) , 1274-1279
- https://doi.org/10.1038/sj.bjp.0701049
Abstract
The objective of the present study was to determine the sites of action of the cytokine, interleukin‐1 (IL‐1), in the febrile response to local inflammation in the rat, by comparing the importance of IL‐1 in the local tissues, the circulation and the brain. This was achieved by injecting lipopolysaccharide (LPS, 100 μg kg−1) into a subcutaneous air pouch and testing the effects of blocking IL‐1 action with the human recombinant interleukin‐1 receptor antagonist (IL‐1ra) injected either into the air pouch, intraperitoneally (1 mg kg−1, 0+1 h, i.p.), or intracerebroventricularly (200 μg/rat, 0+1 h, i.c.v.). To investigate the effect of IL‐1ra on fever and the induction of local and circulating cytokines (IL‐1 and IL‐6), separate experiments were performed in which groups of animals were killed 1.5, 3 or 5 h after LPS injection. Plasma and pouch fluid samples were collected for bioassay of IL‐1 and IL‐6. Injection of LPS into the air pouch significantly increased (1.5°C) body temperature, local (air pouch) concentrations of bioactive IL‐1 and IL‐6, and circulating bioactive IL‐6, compared to saline‐treated controls. Injection of IL‐1ra into the pouch significantly attenuated LPS fever (PPBritish Journal of Pharmacology (1997) 120, 1274–1279; doi:10.1038/sj.bjp.0701049Keywords
This publication has 22 references indexed in Scilit:
- Penetration of interleukin-6 across the murine blood-brain barrierPublished by Elsevier ,2003
- Blood-borne interleukin-1 receptor antagonist crosses the blood-brain barrierJournal of Neuroimmunology, 1994
- Kinetics and correlation with body temperature of circulating interleukin-6, interleukin-8, tumor necrosis factor alpha and interleukin-1 beta in patients with fever and neutropeniaInfection, 1994
- Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody.The Journal of Experimental Medicine, 1991
- Interleukin-1 receptor antagonist reduces mortality from endotoxin shockNature, 1990
- Intracerebroventricular injection of interleukin 1 induces high circulating levels of interleukin 6.The Journal of Experimental Medicine, 1990
- Circulating Interleukin-1 and Tumor Necrosis Factor in Septic Shock and Experimental Endotoxin FeverThe Journal of Infectious Diseases, 1990
- Central actions of interleukin-1β on fever and thermogenesis: N.J. Rothwell1, N.J. Busbridge1, H. Humphray2 & P. Hissey21Dept. of Physiological Sciences, University of Manchester, M13 9PT, & Glaxo Group Research, Greenford UB6 OHE, UKCytokine, 1989
- SERUM LEVELS OF INTERLEUKIN-6 AND ACUTE PHASE RESPONSESThe Lancet, 1987
- The formation of a structure with the features of synovial lining by subcutaneous injection of air: An in vivo tissue culture systemThe Journal of Pathology, 1981